Koppikar Utpal 4
4 · C4 Therapeutics, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
Koppikar Utpal
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-16+41,200→ 41,200 totalExercise: $22.64Exp: 2032-03-15→ Common Stock (41,200 underlying)
Footnotes (1)
- [F1]33% of the shares underlying this option shall vest and become exercisable on March 16, 2023, with the remainder vesting in eight equal quarterly installments thereafter.